- The new lower American Heart Association (AHA) BP targets for patients with chronic kidney disease (CKD) are safe for kidney transplant recipients (KTRs) and potentially beneficial.
Why this matters
- German study of 815 KTRs (mean age, 50.0 years; 60.1% male) stratified by mean office SBP:
- Funding: None disclosed.
- Over a median of 83.5 months, 118 patients resumed dialysis and 110 died.
- Mean SBP
- Benefit appeared driven by a 47% reduction in mortality risk: HR, 0.53 (P=.03).
- Retrospective, cannot show causality.